GRFS logo

Grifois, S.A.


GRFS: As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's biopharma business contributed 83% of sales in 2022. Grifols also has smaller segments including diagnostics and biosupplies. Diagnostics is roughly 10% of revenue (following the Biotest acquisition).


Show GRFS Financials

Consumer Interest
SEC Filings

Recently reported changes by institutional investors

Quarterly net insider trading by GRFS's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of GRFS in WallStreetBets Daily Discussion


Recent insights relating to GRFS

CNBC Recommendations

Recent picks made for GRFS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GRFS

Corporate Flights

Flights by private jets registered to GRFS